SNS Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $268K | Sell |
545
-43
| -7% | -$23.3K | 0.02% | 184 |
|
|
2025
Q4 | $341K | Buy |
588
+33
| +6% | +$18.7K | 0.03% | 156 |
|
|
2025
Q3 | $269K | Sell |
555
-61
| -10% | -$28.4K | 0.02% | 176 |
|
|
2025
Q2 | $250K | Sell |
616
-30
| -5% | -$12.5K | 0.02% | 178 |
|
|
2025
Q1 | $322K | Sell |
646
-47
| -7% | -$25.5K | 0.03% | 144 |
|
|
2024
Q4 | $361K | Sell |
693
-56
| -7% | -$30.8K | 0.04% | 131 |
|
|
2024
Q3 | $464K | Buy |
749
+4
| +0.5% | +$2.37K | 0.05% | 119 |
|
|
2024
Q2 | $412K | Sell |
745
-39
| -5% | -$22.3K | 0.04% | 121 |
|
|
2024
Q1 | $456K | Sell |
784
-119
| -13% | -$66.8K | 0.05% | 121 |
|
|
2023
Q4 | $480K | Sell |
903
-15
| -2% | -$7.26K | 0.06% | 114 |
|
|
2023
Q3 | $465K | Buy |
918
+3
| +0.3% | +$1.6K | 0.06% | 115 |
|
|
2023
Q2 | $478K | Sell |
915
-4
| -0.4% | -$2.16K | 0.06% | 113 |
|
|
2023
Q1 | $530K | Buy |
919
+10
| +1% | +$5.64K | 0.07% | 106 |
|
|
2022
Q4 | $501K | Buy |
909
+11
| +1% | +$5.83K | 0.07% | 111 |
|
|
2022
Q3 | $456K | Buy |
898
+5
| +0.6% | +$2.8K | 0.07% | 113 |
|
|
2022
Q2 | $486K | Buy |
893
+11
| +1% | +$6.05K | 0.06% | 114 |
|
|
2022
Q1 | $521K | Sell |
882
-5
| -0.6% | -$2.87K | 0.06% | 122 |
|
|
2021
Q4 | $592K | Buy |
887
+4
| +0.5% | +$2.5K | 0.06% | 124 |
|
|
2021
Q3 | $505K | Hold |
883
| – | – | 0.06% | 125 |
|
|
2021
Q2 | $445K | Hold |
883
| – | – | 0.06% | 134 |
|
|
2021
Q1 | $403K | Sell |
883
-93
| -10% | -$44.4K | 0.05% | 135 |
|
|
2020
Q4 | $455K | Buy |
976
+20
| +2% | +$9.38K | 0.07% | 126 |
|
|
2020
Q3 | $422K | Sell |
956
-94
| -9% | -$38.8K | 0.07% | 130 |
|
|
2020
Q2 | $380K | Sell |
1,050
-67
| -6% | -$22.5K | 0.07% | 131 |
|
|
2020
Q1 | $316K | Buy |
1,117
+2
| +0.2% | +$631 | 0.06% | 142 |
|
|
2019
Q4 | $362K | Sell |
1,115
-1
| -0.1% | -$303 | 0.06% | 151 |
|
|
2019
Q3 | $325K | Sell |
1,116
-26
| -2% | -$7.45K | 0.06% | 149 |
|
|
2019
Q2 | $335K | Sell |
1,142
-57
| -5% | -$15.7K | 0.06% | 149 |
|
|
2019
Q1 | $328K | Sell |
1,199
-12
| -1% | -$2.99K | 0.07% | 137 |
|
|
2018
Q4 | $272K | Sell |
1,211
-202
| -14% | -$47.4K | 0.07% | 144 |
|
|
2018
Q3 | $344K | Sell |
1,413
-48
| -3% | -$11K | 0.08% | 124 |
|
|
2018
Q2 | $302K | Buy |
1,461
+439
| +43% | +$93.2K | 0.08% | 128 |
|
|
2018
Q1 | $211K | Sell |
1,022
-581
| -36% | -$122K | 0.06% | 149 |
|
|
2017
Q4 | $305K | Sell |
1,603
-453
| -22% | -$86.8K | 0.07% | 136 |
|
|
2017
Q3 | $389K | Sell |
2,056
-50
| -2% | -$9.05K | 0.1% | 115 |
|
|
2017
Q2 | $367K | Sell |
2,106
-42
| -2% | -$7.05K | 0.1% | 118 |
|
|
2017
Q1 | $330K | Buy |
+2,148
| New | +$328K | 0.08% | 131 |
|
|
2014
Q1 | – | Sell |
-3,687
| Closed | -$411K | – | 125 |
|
|
2013
Q4 | $411K | Sell |
3,687
-75
| -2% | -$7.46K | 0.19% | 85 |
|
|
2013
Q3 | $347K | Buy |
+3,762
| New | +$340K | 0.22% | 70 |
|
Other funds holding TMO
VCM
SNS Financial Group's TMO Position: Q1 2026 in Review
SNS Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 7.3% in Q1 2026, selling an estimated $23.3K and leaving 545 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #184.
SNS Financial Group first reported a position in TMO in Q3 2013 and has held it in 39 quarters since. The position peaked at $592K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- SNS Financial Group held 545 shares of Thermo Fisher Scientific worth $268K as of Q1 2026.
- SNS Financial Group sold 43 Thermo Fisher Scientific shares in Q1 2026, an estimated $23.3K.
- Thermo Fisher Scientific made up 0.02% of SNS Financial Group's portfolio in Q1 2026, its #184 holding.
- SNS Financial Group first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 39 quarters since.
- SNS Financial Group's Thermo Fisher Scientific position peaked at $592K in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.